...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii
【24h】

Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii

机译:医院获得性医院内不动杆菌和皮氏不动杆菌感染的临床结局

获取原文
获取原文并翻译 | 示例
           

摘要

The role of Acinetobacter nosocomialis and Acinetobacter pittii, which belong to the A. calcoaceticus-A. baumannii complex, in hospital-acquired infections is increasingly recognized. Here we describe a retrospective cohort study of hospital-acquired A. calcoaceticus-A. baumannii complex infections at a university hospital in Thailand. A total of 222 unique cases were identified between January 2010 and December 2011. The genomospecies of the A. calcoaceticus-A. baumannii complex isolates were classified as follows: A. baumannii, 197 (89%); A. nosocomialis, 18 (8%); and A. pittii, 7 (3%). All A. nosocomialis and A. pittii isolates were susceptible to imipenem and meropenem. The patients infected with A. nosocomialis and A. pittii had lower 30-day mortality than those infected with carbapenem-susceptible A. baumannii (P = 0.025) and carbapenem-resistant A. baumannii (P = 0.013). The factors influencing 30-day mortality were infection with non-baumannii A. calcoaceticus-A. baumannii complex (hazard ratio [HR], 0.12; 95% confidence interval [CI], 0.03 to 0.51; P = 0.004), infection with carbapenem-resistant A. baumannii (HR, 1.57; 95% CI, 0.89 to 2.79; P = 0.105), appropriate empirical antimicrobial therapy (HR, 0.38; 95% CI, 0.23 to 0.61; P < 0.001), and higher acute physiology and chronic health evaluation II (APACHE II) score (HR, 1.15; 95% CI, 1.10 to 1.19; P < 0.001). In Galleria mellonella assays, the survival rates were significantly higher for the larvae infected with A. nosocomialis or A. pittii than for those infected with either carbapenem-susceptible A. baumannii or carbapenem-resistant A. baumannii, but no differences in survival rates were observed between carbapenem-susceptible A. baumannii and carbapenem-resistant A. baumannii. These findings suggest intrinsic differences in virulence between non-baumannii A. calcoaceticus-A. baumannii complex species and A. baumannii but not between carbapenem-susceptible and resistant A. baumannii.
机译:医院不动杆菌和皮氏不动杆菌的作用,它们属于A. calcoaceticus-A。鲍曼复合体,在医院获得性感染中得到越来越多的认可。在这里,我们描述了对医院获得的A. calcoaceticus-A的回顾性队列研究。泰国一家大学医院的鲍曼病毒感染。在2010年1月至2011年12月之间共鉴定出222例独特病例。A. calcoaceticus-A的基因型。鲍曼不动杆菌复合体的分类如下:鲍曼不动杆菌,197(89%);医院菌18岁(8%);和A. pittii,7(3%)。所有的医院内农杆菌和皮氏农杆菌都对亚胺培南和美洛培南敏感。与感染碳​​青霉烯易感性鲍曼不动杆菌(P = 0.025)和耐碳青霉烯的鲍曼不动杆菌(P = 0.013)相比,被医院内曲霉和皮氏杆菌感染的患者的30天死亡率要低。影响30天死亡率的因素是感染了非鲍曼不动杆菌A. calcoaceticus-A。鲍曼复合体(危险比[HR],0.12; 95%置信区间[CI],0.03至0.51; P = 0.004),感染耐碳青霉烯的鲍曼不动杆菌(HR,1.57; 95%CI,0.89至2.79; P = 0.105),适当的经验性抗菌治疗(HR,0.38; 95%CI,0.23至0.61; P <0.001),以及更高的急性生理和慢性健康评估II(APACHE II)评分(HR,1.15; 95%CI,1.10)至1.19; P <0.001)。在梅勒埃勒菌廊试验中,感染了医院内曲霉或皮氏曲霉的幼虫的存活率显着高于接受碳青霉烯敏感的鲍曼不动杆菌或耐碳青霉烯的鲍曼不动杆菌感染的幼虫,但存活率没有差异在易感碳青霉烯的鲍曼不动杆菌和耐碳青霉烯的鲍曼不动杆菌之间观察到。这些发现表明非鲍曼不动杆菌A. calcoaceticus-A之间的内在差异。鲍曼不动杆菌和鲍曼不动杆菌的复杂物种,但不在碳青霉烯易感和耐药鲍曼不动杆菌之间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号